QUMAS Announces The Launch Of A New Biotechnology Package For Growing Biotech Organizations

Main Category: Pharma Industry / Biotech Industry
Article Date: 15 Sep 2009 - 15:00 PDT

email to a friend   printer friendly   opinions  

QUMAS, the leading provider of Compliance Solutions to highly regulated industries, announced the launch of the QUMAS Biotechnology Package, a complete web-based electronic document management system (eDMS) for Biotechnology companies preparing for regulatory submission. This affordable package has been created specifically for small biotech companies, in order to give them access to QUMAS DocCompliance, the leading eDMS used by tier one companies globally. Growing biotechs can now afford a complete eDMS for document control, which is preconfigured with industry practices, and can be validated and live within 30 days.

"We are delighted to be able to provide an affordable offering to smaller companies who can now leverage the same solutions as the leaders in their space in a cost effective and highly efficient package," said Ken Hayward, CTO of QUMAS. "They can also leverage our expertise, as configured in the system, to ensure that they operate a compliant organization from the outset, making them more viable in a regulatory context and more attractive to investors and partners."

The QUMAS Biotechnology package is:

-- Easy and fast to implement -- go live within 30 days
-- Pre-configured with industry standards for regulatory compliance
-- Best of breed document management, which is in used in over 250 facilities globally
-- Extendable and scalable, as the company, the requirements and the infrastructures grow
-- Easy to use with fast track training built in
-- Compatible with all existing documents and processes
-- A cost effective world class solution at an industry leading cost

QUMAS is launching the Biotechnology Package in the EU on September 15, at the DMS Expo in Cologne. QUMAS is launching the Biotechnology Package in the US on September 16, at a Compliance Breakfast Seminar in the Vertex Pharmaceuticals facility in Cambridge, MA. Also speaking at this event will be clients from Vertex Pharmaceuticals and Millennium Pharmaceuticals, along with QUMAS Regulatory experts.

Source
QUMAS

• Additional
• References
• Citations